Search scope:
排序: Display mode:
Metformin and metabolic diseases: a focus on hepatic aspects
Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 173-186 doi: 10.1007/s11684-015-0384-0
Keywords: metformin diabetes hepatic steatosis inflammatory response insulin resistance
Yang Liu, Jiang Peng, Shiya Zhu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai
Engineering 2023, Volume 25, Issue 6, Pages 222-233 doi: 10.1016/j.eng.2022.02.014
Recent studies have revealed the potency of probiotics in alleviating metabolic diseases associatedHowever, an efficient model for screening probiotic strains against specific metabolic diseases has notcell monolayer membrane model for the efficient screening of potential probiotics against specific metabolicdiseases such as osteoporosis and chronic alcoholic liver disease.
Keywords: Lactobacillus Intestinal barrier Caco-2 cells Screening model Metabolic diseases
Frontiers of Environmental Science & Engineering 2022, Volume 16, Issue 8, doi: 10.1007/s11783-022-1527-6
• The promoting effects for VFA generation follow the order of APG>SDBS>HTAB.
Keywords: Waste activated sludge (WAS) Volatile fatty acids (VFA) Surfactant types Functional microorganisms Metabolic
Metabolic hypertension: concept and practice
Zhiming Zhu, Peijian Wang, Shuangtao Ma
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 201-206 doi: 10.1007/s11684-013-0264-4
Keywords: hypertension cardiometabolic risk factors metabolic abnormalities
The Human Microbiota in Health and Disease
Baohong Wang, Mingfei Yao, Longxian Lv, Zongxin Ling, Lanjuan Li
Engineering 2017, Volume 3, Issue 1, Pages 71-82 doi: 10.1016/J.ENG.2017.01.008
Keywords: Microbiome Health Infectious disease Liver diseases Gastrointestinal malignancy Metabolic disorder Microbiota
Jianping Ye
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 139-145 doi: 10.1007/s11684-015-0377-z
In obesity, chronic inflammation is believed to induce insulin resistance and impairs adipose tissue function. Although this view is supported by a large body of literature, it has been challenged by growing evidence that pro-inflammatory cytokines may favor insulin sensitivity through induction of energy expenditure. In this review article, interleukin 15 (IL-15) is used as a new example to explain the beneficial effects of the pro-inflammatory cytokines. IL-15 is secreted by multiple types of cells including macrophages, neutrophils and skeletal muscle cells. IL-15 expression is induced in immune cells by endotoxin and in muscle cells by physical exercise. Its transcription is induced by transcription factor NF-κB. IL-15 binds to its receptor that contains three different subunits (α, β and γ) to activate JAK/STAT, PI3K/Akt, IKK/NF-κB and JNK/AP1 pathways in cells. In the regulation of metabolism, IL-15 reduces weight gain without inhibiting food intake in rodents. IL-15 suppresses lipogenesis, stimulates brown fat function, improves insulin sensitivity through weight loss and energy expenditure. In human, circulating IL-15 is negatively associated with body weight. In the immune system, IL-15 stimulates proliferation and differentiation of T cells, NK cells, monocytes and neutrophils. In the anti-obesity effects of IL-15, T cells and NK cells are not required, but leptin receptor is required. In summary, evidence from human and rodents supports that the pro-inflammatory cytokine IL-15 may enhance energy expenditure to protect the body from obesity and type 2 diabetes. The mechanism of IL-15 action remains to be fully uncovered in the regulation of energy expenditure.
Keywords: inflammation obesity cytokine energy expenditure insulin resistance
Frontiers of Medicine 2021, Volume 15, Issue 5, Pages 679-692 doi: 10.1007/s11684-021-0866-1
Keywords: metabolic reprogramming potential of electron transfer cell proliferation aerobic glycolysis cancer
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 25-30 doi: 10.1007/s11684-013-0244-8
Keywords: FGF21 metabolism pharmacology physiology clinical relevance
Laparoscopic treatment of liver diseases in children
Jia Wei, Jiexiong Feng
Frontiers of Medicine 2011, Volume 5, Issue 4, Pages 388-394 doi: 10.1007/s11684-011-0165-3
Keywords: laparoscopic surgery liver mass pediatric
Frontiers of Environmental Science & Engineering 2021, Volume 15, Issue 6, doi: 10.1007/s11783-021-1433-3
• Short-term effect of the pyridine exposure on the SAD process was investigated.
Keywords: Anammox Inhibition Metabolic pathway Microbial community Pyridine SAD
Prevalence of cardiovascular diseases in China
Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD,
Frontiers of Medicine 2010, Volume 4, Issue 1, Pages 16-20 doi: 10.1007/s11684-010-0007-8
Keywords: cardiovascular diseases prevalence China risk factors prevention
Water-dispersible nano-pollutions reshape microbial metabolism in type-specific manners: A metabolic
Frontiers of Environmental Science & Engineering 2022, Volume 16, Issue 9, doi: 10.1007/s11783-022-1548-1
• Water-dispersible nano-pollutions exhibit type-specific toxic effects on E. coli.
Keywords: Nano-toxicity Nano-plastics Quantum dots Microbial metabolite Metabolic dysregulation
Xiaokun Li
Frontiers of Medicine 2019, Volume 13, Issue 5, Pages 511-530 doi: 10.1007/s11684-019-0711-y
Keywords: FGF19 FGF21 FGF23 FGFR metabolism endocrine Klotho
Xiaohong Duan, Thomas Markello, David Adams, Camilo Toro, Cynthia Tifft, William A. Gahl, Cornelius F. Boerkoel
Frontiers of Medicine 2013, Volume 7, Issue 3, Pages 389-394 doi: 10.1007/s11684-013-0281-3
Keywords: genetics cultural differences undiagnosed diseases program
Diagnosis and therapy of lacrimal system diseases by micro lacrimal endoscope
Nan XIANG, Weikun HU, Jing YUAN, Guigang LI, Haixia LIU
Frontiers of Medicine 2009, Volume 3, Issue 1, Pages 113-117 doi: 10.1007/s11684-009-0001-1
Keywords: lacrimal apparatus diseases endoscopes
Title Author Date Type Operation
Metformin and metabolic diseases: a focus on hepatic aspects
Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu
Journal Article
A Screening Model for Probiotics Against Specific Metabolic Diseases Based on Caco-2 Monolayer Membrane
Yang Liu, Jiang Peng, Shiya Zhu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai
Journal Article
New insights into different surfactants’ impacts on sludge fermentation: Focusing on the particular metabolic
Journal Article
Metabolic hypertension: concept and practice
Zhiming Zhu, Peijian Wang, Shuangtao Ma
Journal Article
The Human Microbiota in Health and Disease
Baohong Wang, Mingfei Yao, Longxian Lv, Zongxin Ling, Lanjuan Li
Journal Article
Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes
Jianping Ye
Journal Article
electron transfer and its application in dictating routes of biochemical processes associated with metabolic
Journal Article
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Huating Li, Jing Zhang, Weiping Jia
Journal Article
denitrification system with short-term pyridine exposure: Process capability, inhibition kinetics and metabolic
Journal Article
Prevalence of cardiovascular diseases in China
Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD,
Journal Article
Water-dispersible nano-pollutions reshape microbial metabolism in type-specific manners: A metabolic
Journal Article
Cultural differences define diagnosis and genomic medicine practice: implications for undiagnosed diseases
Xiaohong Duan, Thomas Markello, David Adams, Camilo Toro, Cynthia Tifft, William A. Gahl, Cornelius F. Boerkoel
Journal Article